| 3 years | 1.94 |  | 6.71 |
| 5 years | 1.94 | | 12.75 |
| 10 years | 1.94 | | 18.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 49 | 07/10/2025 |
| Director of Finance/CFO | 50 | 07/10/2025 | |
David Thomson
SEC | Corporate Secretary | 59 | 07/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Castagna
BRD | Director/Board Member | 49 | 07/10/2025 |
David Thomson
BRD | Director/Board Member | 59 | 07/10/2025 |
| Director/Board Member | 50 | 07/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/10/25 | Issuer sale | Director | 72,174 | 0.1442% | ||
| 7/10/25 | Issuer sale | Director | 84,422 | 0.1687% | ||
| 7/10/25 | Issuer sale | Director | 49,750 | 0.0994% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 305M | |
| -0.18% | -3.96% | +45.23% | +128.75% | 1,216B | |
| +1.04% | +0.82% | +47.32% | +81.57% | 656B | |
| +0.46% | -1.57% | +32.52% | +105.57% | 509B | |
| -0.36% | -3.25% | +47.17% | +64.58% | 384B | |
| -0.24% | -1.91% | +70.98% | +40.56% | 362B | |
| -0.78% | -0.52% | +30.57% | +57.98% | 311B | |
| -0.80% | -0.21% | +8.54% | +35.56% | 293B | |
| +0.11% | -0.92% | +46.31% | +69.24% | 249B | |
| +0.04% | -1.66% | +36.02% | +106.86% | 208B | |
| Average | -0.14% | +0.60% | +40.52% | +76.74% | 465.31B | |
| Weighted average by Cap. | -0.05% | +0.03% | +42.37% | +88.63% |
Employees
163
Sector
Pharmaceuticals
